Literature DB >> 22231379

Intellectual and neurological functioning in Morquio syndrome (MPS IVa).

J E Davison1, S Kearney, J Horton, K Foster, A C Peet, C J Hendriksz.   

Abstract

Mucopolysaccharidosis type IVa (MPS IVa, Morquio syndrome OMIM #253000) is a lysosomal storage disease caused by deficiency in N-acetylgalactosamine-6-sulfatase (GALNS, EC 3.1.6.4; encoded by GALNS gene at 16q24.3). Unlike other MPS disorders involving excessive heparan and dermatan sulfate, Morquio syndrome has not been associated with neurological involvement nor with intellectual impairment as this disorder of keratan sulfate has been described as a purely visceral and skeletal disorder. Neurocognitive assessment was undertaken of MPS IVa patients with age appropriate intellectual tests as well as a Child Behaviour Checklist as part of clinical follow up. Available neuroimaging studies (MRI and MR spectroscopy) were reviewed. Whilst more than half of the overall IQ scores fell in the average range, scores for 3/8 children fell below average. A number of behavioural problems were highlighted, including anxiety/depression, attention and somatic complaints. Subtle neuroimaging abnormalities were demonstrated in over half of the children. These findings present a challenge to existing assumptions about the nature of Morquio A syndrome. A hypothesis regarding the potential role of calcium signalling is explored.

Entities:  

Mesh:

Year:  2012        PMID: 22231379     DOI: 10.1007/s10545-011-9430-5

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN: 0141-8955            Impact factor:   4.982


  24 in total

1.  Natural progression of neurological disease in mucopolysaccharidosis type II.

Authors:  Joshua B Holt; Michele D Poe; Maria L Escolar
Journal:  Pediatrics       Date:  2011-04-25       Impact factor: 7.124

Review 2.  Common and uncommon pathogenic cascades in lysosomal storage diseases.

Authors:  Einat B Vitner; Frances M Platt; Anthony H Futerman
Journal:  J Biol Chem       Date:  2010-04-29       Impact factor: 5.157

3.  Ca2+ homeostasis modulation enhances the amenability of L444P glucosylcerebrosidase to proteostasis regulation in patient-derived fibroblasts.

Authors:  Fan Wang; Giulia Agnello; Natasha Sotolongo; Laura Segatori
Journal:  ACS Chem Biol       Date:  2010-11-10       Impact factor: 5.100

4.  Quantitative in vivo brain magnetic resonance spectroscopic monitoring of neurological involvement in mucopolysaccharidosis type II (Hunter Syndrome).

Authors:  James E Davison; Christian J Hendriksz; Yu Sun; Nigel P Davies; Paul Gissen; Andrew C Peet
Journal:  J Inherit Metab Dis       Date:  2010-10-01       Impact factor: 4.982

5.  The Morquio syndrome: neuropathology and biochemistry.

Authors:  A Koto; A L Horwitz; K Suzuki; C W Tiffany; K Suzuki
Journal:  Ann Neurol       Date:  1978-07       Impact factor: 10.422

6.  Hypersociability in Williams syndrome: a role for the amygdala?

Authors:  Ali Jawaid; Heike Schmolck; Paul E Schulz
Journal:  Cogn Neuropsychiatry       Date:  2008-07       Impact factor: 1.871

7.  Enzyme replacement therapy in a murine model of Morquio A syndrome.

Authors:  Shunji Tomatsu; Adriana M Montaño; Amiko Ohashi; Monica A Gutierrez; Hirotaka Oikawa; Toshihiro Oguma; Vu Chi Dung; Tatsuo Nishioka; Tadao Orii; William S Sly
Journal:  Hum Mol Genet       Date:  2007-12-03       Impact factor: 6.150

8.  Enzyme replacement in a human model of mucopolysaccharidosis IVA in vitro and its biodistribution in the cartilage of wild type mice.

Authors:  Melita Dvorak-Ewell; Dan Wendt; Chuck Hague; Terri Christianson; Vish Koppaka; Danielle Crippen; Emil Kakkis; Michel Vellard
Journal:  PLoS One       Date:  2010-08-16       Impact factor: 3.240

9.  MR spectroscopy-based brain metabolite profiling in propionic acidaemia: metabolic changes in the basal ganglia during acute decompensation and effect of liver transplantation.

Authors:  James E Davison; Nigel P Davies; Martin Wilson; Yu Sun; Anupam Chakrapani; Patrick J McKiernan; John H Walter; P Gissen; Andrew C Peet
Journal:  Orphanet J Rare Dis       Date:  2011-05-09       Impact factor: 4.123

10.  Abnormal autophagy, ubiquitination, inflammation and apoptosis are dependent upon lysosomal storage and are useful biomarkers of mucopolysaccharidosis VI.

Authors:  Alessandra Tessitore; Marinella Pirozzi; Alberto Auricchio
Journal:  Pathogenetics       Date:  2009-06-16
View more
  17 in total

1.  Diagnosis of Morquio-A patients in Mexico: How far are we from prompt diagnosis?

Authors:  Douglas Colmenares-Bonilla; Nayeli Esquitin-Garduño
Journal:  Intractable Rare Dis Res       Date:  2017-05

2.  Psychological health in adults with morquio syndrome.

Authors:  Nadia Ali; S Cagle
Journal:  JIMD Rep       Date:  2015-01-23

3.  Hearing Loss in Patients With Morquio Syndrome: Protocol for a Scoping Review.

Authors:  Lorena Diaz-Ordoñez; Estephania Candelo; Katherine Silva-Cuero; Wilmar Saldarriaga; Lenka Murgašová; Martin Magner; Harry Pachajoa
Journal:  JMIR Res Protoc       Date:  2022-06-07

Review 4.  Molecular genetics and metabolism, special edition: Diagnosis, diagnosis and prognosis of Mucopolysaccharidosis IVA.

Authors:  Hira Peracha; Kazuki Sawamoto; Lauren Averill; Heidi Kecskemethy; Mary Theroux; Mihir Thacker; Kyoko Nagao; Christian Pizarro; William Mackenzie; Hironori Kobayashi; Seiji Yamaguchi; Yasuyuki Suzuki; Kenji Orii; Tadao Orii; Toshiyuki Fukao; Shunji Tomatsu
Journal:  Mol Genet Metab       Date:  2018-05-15       Impact factor: 4.797

Review 5.  Review of clinical presentation and diagnosis of mucopolysaccharidosis IVA.

Authors:  C J Hendriksz; P Harmatz; M Beck; S Jones; T Wood; R Lachman; C G Gravance; T Orii; S Tomatsu
Journal:  Mol Genet Metab       Date:  2013-04-10       Impact factor: 4.797

6.  Current and emerging management options for patients with Morquio A syndrome.

Authors:  Mohamed F Algahim; G Hossein Almassi
Journal:  Ther Clin Risk Manag       Date:  2013-02-11       Impact factor: 2.423

Review 7.  International guidelines for the management and treatment of Morquio A syndrome.

Authors:  Christian J Hendriksz; Kenneth I Berger; Roberto Giugliani; Paul Harmatz; Christoph Kampmann; William G Mackenzie; Julian Raiman; Martha Solano Villarreal; Ravi Savarirayan
Journal:  Am J Med Genet A       Date:  2014-10-24       Impact factor: 2.802

Review 8.  Spinal involvement in mucopolysaccharidosis IVA (Morquio-Brailsford or Morquio A syndrome): presentation, diagnosis and management.

Authors:  Guirish A Solanki; Kenneth W Martin; Mary C Theroux; Christina Lampe; Klane K White; Renée Shediac; Christian G Lampe; Michael Beck; William G Mackenzie; Christian J Hendriksz; Paul R Harmatz
Journal:  J Inherit Metab Dis       Date:  2013-02-06       Impact factor: 4.982

9.  Imaging findings of mucopolysaccharidoses: a pictorial review.

Authors:  Stefano Palmucci; Giancarlo Attinà; Maria Letizia Lanza; Giuseppe Belfiore; Giuseppina Cappello; Pietro Valerio Foti; Pietro Milone; Domenico Di Bella; Rita Barone; Agata Fiumara; Giovanni Sorge; Giovanni Carlo Ettorre
Journal:  Insights Imaging       Date:  2013-05-05

10.  Home infusion with Elosulfase alpha (VimizimR) in a UK Paediatric setting.

Authors:  Niamh Finnigan; Jane Roberts; Jean Mercer; Simon A Jones
Journal:  Mol Genet Metab Rep       Date:  2017-11-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.